SCHEMBL6561681

SCHEMBL6561681

COC(=O)C(C)c1ccc(SC(=O)N(C)C)c(Cl)c1[Se]c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6561512 0.81 MT-CO2 (0.35) KMT2A
SCHEMBL6560067 0.69 MT-CO2 (0.40) PTGS1PTGS2
SCHEMBL11889215 0.62 NCEH1 (0.52) KMT2A
SCHEMBL10732086 0.62 JAK2 (0.40) KMT2A
SCHEMBL13403891 0.62 CXCL8 (0.46) PTGS1PTGS2KMT2A
SCHEMBL5706168 0.62 CXCL8 (0.46) PTGS1PTGS2KMT2A
SCHEMBL31612955 0.62 CXCL8 (0.46) PTGS1PTGS2KMT2A
SCHEMBL3418020 0.61 MT-CO2 (0.41) PTGS1PTGS2KMT2A
SCHEMBL7042944 0.61 ACLY (0.35) KMT2A
SCHEMBL4735455 0.61 GABRA1 (0.39) PTGS1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0904079-B1 ANTIDIABETIC AGENTS MERCK & CO INC (US) 2004-03-24 EP disclosed
EP-0904079-A4 1999-05-06 EP disclosed
EP-0904079-A1 ANTIDIABETIC AGENTS Merck & Co., Inc. (US) 1999-03-31 EP disclosed
US-5859051-A ACETYLPHENOL DERIVATIVES MERCK & CO., INC. (US) 1999-01-12 US disclosed
WO-1997027857-A1 ANTIDIABETIC AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed